Hyperthermia in oncology
Whole-body and local-regional hyperthermia alongside standard cancer treatment; more than 30,000 whole-body sessions on our ward.
Evidence on the hyperthermia pageRosenheimer Str. 6-8, 83043 Bad Aibling, Germany · info@clinicum-stgeorg.de
Research & Science
The clinical areas St. George Hospital works in, each linked to the page where the evidence for it is graded. A publication list follows once every entry has been checked against library and PubMed records.
St. George Hospital took up oncology and biological medicine in 1991, Lyme disease in 1995, and more recently Post-COVID and ME/CFS with apheresis. For each area, the therapy or condition page carries the evidence section: what has been studied, in which patients, and how strong the evidence is.
Whole-body and local-regional hyperthermia alongside standard cancer treatment; more than 30,000 whole-body sessions on our ward.
Evidence on the hyperthermia pageLow-dose chemotherapy with insulin (IPT), immune modulation and supportive therapies, added to surgery, chemotherapy and radiotherapy, never in their place.
Evidence on the IPT pageMultimodal inpatient treatment with whole-body hyperthermia, antimicrobial therapy and immune support; more than 12,000 patients since 1995.
Evidence on the Lyme disease hubMicrocirculation, fibrinoid microclots and endothelial dysfunction in Long COVID and ME/CFS, the research direction of Dr. Beate Jaeger.
Evidence on the Post-COVID hubLight-activated sensitizers in cancer treatment, decided case by case after medical consultation.
Evidence on the photodynamic therapy pageH.E.L.P. apheresis, immunoadsorption, double cascade filtration and plasma exchange, and the conditions in which each has been studied.
Evidence on the apheresis page| Grade | What it means | Typical basis |
|---|---|---|
| Strong | Consistent results in the population named on the page | Controlled trials or consistent cohort data |
| Moderate | Supportive results with limits | Trials or cohorts limited in size, design or population |
| Emerging | Early clinical signals | Early clinical data, case series or ongoing studies |
| Limited | Plausible, not yet tested in trials | Mechanism, small series or clinical experience only |
The grade applies to the proposed use, not to the method in general: hyperthermia alongside radiotherapy in one tumor type is graded differently from hyperthermia in a chronic infection. It describes the literature on the review date, not your case.
Research claims on our therapy and condition pages link to the PubMed record they rest on, so you can read the abstract and check whether the population matches your situation. The grade is written by the reviewing physician from the cited records and changes when a new trial changes the picture. Our treatment outcomes describes what the hospital records in each program.
Dr. Friedrich Douwes (1945–2022) founded the hospital in 1991 and worked in integrative oncology and Lyme disease. He introduced whole-body hyperthermia on the ward and began the Lyme program in 1995. His papers, book contributions and conference presentations, and those of the current medical team, are being compiled into one bibliography, with author, title, journal, year and identifier checked for each entry.
Physicians and researchers who need a specific reference can write to info@clinicum-stgeorg.de with the topic and year.

Start with the page closest to your situation: chronic Lyme disease, Long COVID and ME/CFS, integrative oncology or hyperthermia. Then send a short inquiry; the International Office replies and arranges a video consultation about what the evidence means for you.
The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.
Munich Airport (MUC), about 60 minutes by car.